Faro Health, Inc. Market Research Report
Company Overview
- Name: Faro Health, Inc.
- Mission: Faro Health is dedicated to making clinical development more data-driven, streamlined, and efficient. They empower clinical study teams to design optimized clinical protocols in a digital-native way, reducing patient and site burden, costs, and complexity, while laying the foundation for downstream data flow and process automation.
- Founded: 2019
- Founder: Scott Chetham
- Key People:
- Scott Chetham, PhD, CEO & Co-Founder
- Patrick Leung, CTO
- Vivian DeWoskin, Chief Strategy Officer
- Headquarters: 9645 Scranton Rd, Suite 170, San Diego, CA 92121, USA
- Number of Employees: 11-50
- Revenue: No information available
- Known For: Specializing in cloud-based software that improves the design and optimization of clinical trial protocols.
Products
Study Designer
A tool designed to create, optimize, and start up trials more efficiently using powerful AI tools.
Key Features
- AI Capabilities: Uses AI to bring new levels of insight and confidence in clinical trial design.
- User-friendly Interface: Praised for its ease of use, particularly by medical writers and clinical development directors.
- Collaborative Tools: Enables study teams to design protocols with collaborative, data-driven insights.
- Protocol Representation: Represents study designs as structured data to facilitate automation and integration with downstream processes.
- Generative AI for Protocol Writing: Accelerates the writing of clinical protocol documents by utilizing large language models (LLMs).
Recent Developments
New Partnerships
- Recursion Partnership: Faro Health has partnered with Recursion to optimize clinical protocol design using AI. This alliance aims to design and simulate better clinical trials and accelerate enrollment.
Funding and Financial Growth
- Series A Funding: Faro Health secured $15 million in Series A financing with additional funding rounds reported in 2023, bringing the total to $20 million led by General Catalyst and other investors.
New Features Added
- Harnessing Gen AI for Clinical Protocol Authoring: Faro Health has developed a robust AI-based authoring system to shorten the time for drafting clinical protocols, improving the initial draft quality and reducing reliance on manual processes.
Strategic Initiatives
- Change Management Approach: Focuses on integrating SaaS technology into clinical workflows, ensuring smooth transitions and empowering teams to leverage AI capabilities for more efficient protocol design.
Market Presence
- Continuous Expansion: Faro Health actively participates in major conferences like SCOPE and CMO Summit 360, sharing insights and expanding industry connections.
- Awards and Recognition: Recognized as the winner of DPHARM Idol Disrupt and strategically partnered with programs like Microsoft for Startups to enhance clinical protocol design.
This structured, professional report encapsulates the core elements of Faro Health, Inc., providing valuable insights into its strategic operations, product offerings, and market endeavors.